Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Invertebrate glutamate-gated chloride channels (GluCls) are members of the Cys-loop family of ligand-gated ion channels that mediate fast inhibitory neurotransmission in protostome invertebrates, such as nematodes and arthropods (Wolstenholme, 2012). These channels are activated by the neurotransmitter L-glutamate, leading to an influx of chloride ions that hyperpolarizes the cell membrane and inhibits electrical activity (Hibbs & Gouaux, 2011). A defining feature of GluCls is their absence in vertebrate genomes, which makes them an ideal target for highly selective antiparasitic and insecticidal agents (Cully et al., 1994). The most prominent drugs targeting these channels are the macrocyclic lactones, including ivermectin, which act as potent positive allosteric modulators that stabilize the open state of the channel (Lynagh & Lynch, 2012). This action results in the flaccid paralysis of the parasite's somatic muscles and pharynx, preventing movement and feeding, and eventually leading to the death of the organism (Wolstenholme, 2012). In clinical practice, these channels are central to the treatment of human diseases like onchocerciasis and various veterinary parasitic infections, though their utility is increasingly threatened by the emergence of drug resistance (Menez et al., 2012).
Positive allosteric modulation and agonism of the channel, leading to increased chloride ion permeability, hyperpolarization of neurons and muscle cells, and subsequent flaccid paralysis (Wolstenholme, 2012).
10 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Invertebrate glutamate-gated chloride channel (GluCl) (GluCl).